ResMed provides sleep medications and non-invasive ventilation based on a visionary technology shifting diagnosis, treatment, and management of breathing sleep disorder. They treat sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. All of the Company’s current efforts are involved with sleep apnea/hypopnea, respiratory depression and respiratory distress.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Sorin CRM SAS designs and manufactures implantable pacemakers and defibrillators. It offers ICDs, leads, holter equipment, and electrophysiology catheters. The company was founded on July 25, 1977 and is headquartered in Clamart, France.

Linde GmbH is a holding company, which engages in the gas and engineering business. It operates through the following division: Gases, Engineering, and Other Activities. The Gases Division offers a wide range of compressed and liquefied gases as well as chemicals. The Engineering Division delivers olefin, natural gas, air separation, hydrogen, and synthesis gas plants. The Other Activities Division comprises operations of logistics services company Gist. The company was founded by Carl Paul Gottfried von Linde on June 21, 1879 and is headquartered in Munich, Germany.

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Part of ResMed, Inc., ResMed Paris SAS is a French company located in Saint priest. The firm manufactures medical, surgical and dental equipment.

ResMed is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB), includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. It has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. Its manufacturing operations are located in Australia, Singapore, France and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Norway and Sweden. On October 1, 2009, it acquired 100% of Laboratoires Narval SA. Laboratoires Narval manufactures and distributes a mandibular repositioning device (MRD).

Shenzhen Haiwen Biotechnology Co., Ltd., established on 2018-11-16, Business scope includes general business items:Sanitation products,Daily necessities,Office Supplies,electronic product,baby products,hygiene products,Disinfection equipment,textile,cosmetic,Fitness Equipment,Health Supplies,household appliances,handcrafted gift(Except for ivory and its products),gifts,Knitwear and Raw Materials,Class I medical device,Class II medical device,daily necessities,Technology development of computer software,buy and sell;Domestic Trade(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council);Import of goods and technology(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:Family Planning Supplies(Does not contain drugs),Technology Development of Ai Products,buy and sell;electronic product,household appliances,Production of massagers;Production of Class I Medical Devices.food sales(Only sell prepackaged food);Production of Class II Medical Devices;Food Internet Sales(Only sell prepackaged food).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ.